Not a traditional drug phase: Hip arthroplasty for Femoral Neck Fractures
This study is an intervention domain of the Musculoskeletal Adaptive Platform Trial. The primary goal of this pragmatic, randomly assigned, open-label, comparative effectiveness trial is to evaluate if arthroplasty is superior to internal fixation when used to treat minimally displaced femoral neck fractures in older adults ≥60 years old.
Official registry: https://clinicaltrials.gov/study/NCT07244211 · University of Southern California · enrollment listed as 600
What this phase means
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are Hip arthroplasty, or Internal fixation. The registry lists allocation as randomized. This study is an intervention domain of the Musculoskeletal Adaptive Platform Trial.
They plan to enroll about 600 people at 32 sites. Taking part typically means a procedure as part of the study plus check-ins.
Official title (unrewritten)
Musculoskeletal Adaptive Platform Trial (MAPT): Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
Interventions: Hip arthroplasty, Internal fixation
Primary outcome (registry wording): Composite outcome of death, ambulation status, and days alive and out of hospital.
Who it is for (from inclusion criteria)
- Ages 60 Years to any
- 60 years of age or older undergoing surgery due to a minimally displaced femoral neck fracture
- The patient has a health condition affecting physical mobility
- Complete fracture of the femoral neck (AO/OTA 31B) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging
- Minimally displaced fracture that could be, in the judgment of the attending surgeon, managed with either arthroplasty or in situ internal fixation without reduction
- Low energy injury mechanism
- Surgeons with expertise in internal fixation and total hip arthroplasty or hemiarthroplasty are available to perform surgery
Who the registry excludes
- The patient is not clinically suitable for either compared treatment
- Expected injury survival of less than 12 months
- Terminal illness with expected survival of less than 12 months
- Problems, in the judgment of the study personnel, with maintaining follow-up with the patient
- Currently enrolled in a study or intervention domain that does not permit co-enrollment
- Prior enrollment in the specific platform trial intervention domain
- Eligible patient or legally authorized representative was not approached within the screening window (missed participant)
Public study contact (from the registry)
Joseph Patterson, MD
OrthoTraumaResearch@med.usc.edu
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
32 listed- University of California, Irvine — Irvine, California (recruiting)
- Los Angeles General Medical Center — Los Angeles, California (recruiting)
- University of Southern California — Los Angeles, California (recruiting)
- Cedars-Sinai Medical Center — Los Angeles, California (recruiting)
- University of California San Francisco — San Francisco, California (recruiting)
- University of Miami — Miami, Florida (not_yet_recruiting)
- Indiana University — Bloomington, Indiana (recruiting)
- University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center — Baltimore, Maryland (recruiting)
- University of Maryland Capital Region Health — Largo, Maryland (recruiting)
- Massachusetts General Brigham — Boston, Massachusetts (recruiting)
- Beth Israel Deaconess Medical Center — Boston, Massachusetts (not_yet_recruiting)
- University of Mississippi — University, Mississippi (recruiting)
+ 10 sites outside the US on the same record
FAQ about this NCT record
Is NCT07244211 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT07244211?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT07244211?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary